Results 141 to 150 of about 2,450 (168)
Some of the next articles are maybe not open access.
Genitourinary Syndrome of Menopause: Prevalence and Predictors
Clinical Obstetrics & Gynecology, 2023The genitourinary syndrome of menopause (GSM) has been proposed as a diagnosis by a consensus of clinicians and investigators. Our purpose for this paper is to review extant evidence about: 1) the breadth of symptoms and symptom clusters as related to the syndrome; 2) the prevalence of GSM (includes vulvar and vaginal atrophy); 3) factors that are ...
NANCY F. WOODS +2 more
openaire +2 more sources
Laser Therapy for Genitourinary Syndrome of Menopause
Current Urology Reports, 2018The purpose of this article is to review the available data regarding the application and therapeutic outcomes of laser therapy for the treatment of genitourinary syndrome of menopause (GSM).There have been several studies regarding the use of laser therapy for the treatment of GSM. Most of these studies show a trend toward safe and effective treatment
Andrew, Rabley +4 more
openaire +2 more sources
A Dermatologist’s Approach to Genitourinary Syndrome of Menopause
Journal of Cutaneous Medicine and Surgery, 2017Background: Genitourinary syndrome of menopause (GSM) is a debilitating condition caused by hypoestrogenism that presents with vaginal dryness and dyspareunia as well as other genital, sexual, and urinary symptoms. Previously known as atrophic vaginitis, the term GSM is now used.
Matthew, Hum, Marlene, Dytoc
openaire +2 more sources
Genitourinary syndrome of menopause
The Nurse Practitioner, 2016Genitourinary syndrome of menopause (GSM) is the new name for the conditions that formerly included vulvovaginal atrophy and atrophic vaginitis. GSM better describes the range of conditions associated with low estrogen levels in menopause and invites patient discussion without the use of words that might be uncomfortable to say.
Katherine, Ward, Angela, Deneris
openaire +4 more sources
Diagnosis and Treatment of Genitourinary Syndrome of Menopause
Nursing for Women's Health, 2018Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life.
Ashley L, Hodges +3 more
openaire +2 more sources
Androgens and genitourinary syndrome of the menopause
La Rivista Italiana di Ostetricia e Ginecologia, 2021Why androgens – testosterone and dehydroepiandrosterone (DHEA) – can play a role in the treatment of Genitourinary Syndrome of Menopause? What evidence supports this? Androgens are essential sex hormones for women’s health. Biological evidence (“bio-evidence”) indicates the following: androgens reach high plasma levels in childbearing age; have cell ...
openaire +1 more source
Foreword: Genitourinary Syndrome of Menopause
Clinical Obstetrics & Gynecology, 2023openaire +2 more sources
The “Genitourinary Syndrome of Menopause”
Journal of Lower Genital Tract Disease, 2015Pedro, Vieira-Baptista +2 more
openaire +2 more sources
Menopausal Changes in the Microbiome—A Review Focused on the Genitourinary Microbiome
Diagnostics, 2023Min Gu Park, Seok Cho, Mi Mi Oh
exaly
Risk factors and pathogenetic mechanisms of genitourinary menopausal syndrome
Russian Bulletin of Obstetrician-Gynecologist, 2023E D Dolgov, L M Mikhaleva
exaly